欢迎访问《中国临床药理学与治疗学》杂志官方网站,今天是 分享到:

中国临床药理学与治疗学 ›› 2011, Vol. 16 ›› Issue (7): 768-771.

• 临床药理学 • 上一篇    下一篇

基因芯片法检测自疑药源性耳聋患者基因突变35例

魏绍煌1, 郭舜民2, 林文津2   

  1. 1福建医科大学附属第二医院药剂科,泉州 362000,福建
    2福建省医学科学研究院,福建省医学测试重点实验室,福州 350001,福建
  • 收稿日期:2011-04-18 修回日期:2011-05-30 出版日期:2011-07-26 发布日期:2011-09-22
  • 通讯作者: 林文津,男,助理研究员,研究方向:药物不良反应及个体化用药。E-mail: lwjin@sina.com
  • 作者简介:魏绍煌,男,主管药师,研究方向:医院药学。Tel: 15880918778 E-mail: weishaohuang@126.com
  • 基金资助:
    福建省自然科学基金资助项目(2010J01024);福建省科技厅省属公益院所基本专项资助项目(2011R1101024-2)

Analysis of gene mutation in 35 cases self-doubt hearing loss of patients related to drug-induced using DNA microarray

WEI Shao-huang1, GUO Shun-min2, LIN Wen-jin2   

  1. 1The Second Hospital Affiliated to Fujian Medical University, Quanzhou 362000, Fujian, China;
    2Fujian Acadamy of Medical Sciences, Fujian Key Laboratory of Medical Measurement, Fuzhou 350001, Fujian, China
  • Received:2011-04-18 Revised:2011-05-30 Online:2011-07-26 Published:2011-09-22

摘要: 目的: 对自疑药源性非综合征型耳聋患者进行中国人常见耳聋基因的突变分析,以明确其分子病因。方法: 收集35名自疑非综合征药源性耳聋患者的外周血样本,常规方法提取基因组DNA,进行基因芯片分析。对突变患者的基因,进行PCR 扩增,扩增产物经 DNA 测序分析,并与NCBI GenBank 数据库进行比对,从而对耳聋相关基因的突变进行分析。结果: 35名自疑非综合征耳聋患者中检出已知的mtDNA 12SrRNA 基因罕见致病突变C1494T 1例,占 2.86%,其余为野生型或是其他基因突变。结论: 在临床自疑药物性聋病患者中真正与线粒体基因突变相关的仅占少数, 48临床开展药源性耳聋基因检测时,最好同时进行其他耳聋相关基因的检测,而基因芯片检测是其中一项很好的方法。

关键词: 基因芯片, 测序法, 药源性耳聋, 线粒体基因, C1494T

Abstract: AIM: To investigate the gene mutation in self-doubt related to drug-induced hearing loss patients of non-syndromic sensorineural hearing loss and identify the molecular etiopathogenisis.METHODS: Peripheral blood samples were obtained from 35 cases self-doubt hearing loss of patients collected by out-patient clinic. Their genomic DNA was extracted from peripheral blood by extraction kits to undergo polymerase chain reaction, Gene microarray and sequencing so as to detect the mutations of mitochondrial 12S rRNA gene.RESULTS: In 35 patients, one mutation was found out in mtDNA 12S rRNA gene C1494T (2.86%), the other were wild type or other DNA mutations.CONCLUSION: Only a minority of drug-induced hearing loss associated with Mitochondrial DNA mutations amongst clinical self-doubt patients. The other deafness genes test simultaneously would be better. And gene microarray is one of a new and good method suggested.

Key words: Gene microarray, Drug-induced hearing loss, Self-doubt, 12S rRNA, C1494T

中图分类号: